FDA opens door to the US biosimilars market
International Law Office (registration)-2 hours ago
March 6 2015 marked a turning point for the emerging US biosimilars market. The Food and Drug Administration (FDA) approved Sandoz's application to market ...
No comments:
Post a Comment